Mark Toleman

Dr. Mark Toleman

Deptment of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2010 in The Lancet Infectious Diseases
Verified
Journal Article
Open access
KKKarthikeyan K Kumarasamy
Karthikeyan K Kumarasamy
Mark TolemanMark Toleman
Mark Toleman
TWTimothy R. Walsh
Timothy R. Walsh
JBJay Bagaria
Jay Bagaria
FBFafhana Butt
Fafhana Butt
NWNeil Woodford
Neil Woodford
Gram-negative Enterobacteriaceae with resistance to carbapenem conferred by New Delhi metallo-beta-lactamase 1 (NDM-1) are potentially a major global health problem. We investigated the prevalence of NDM-1, in multidrug-resistant Enterobacteriaceae in India, Pakistan, and the UK. Enterobacteriaceae isolates were studied from two major centres in India--Chennai (south India), Haryana (north India)--and those referred to the UK's national reference laboratory. Antibiotic susceptibilities were assessed, and the presence of the carbapenem resistance gene bla(NDM-1) was established by PCR. Isolates were typed by pulsed-field gel electrophoresis of XbaI-restricted genomic DNA. Plasmids were analysed by S1 nuclease digestion and PCR typing. Case data for UK patients were reviewed for evidence of travel and recent admission to hospitals in India or Pakistan. We identified 44 isolates with NDM-1 in Chennai, 26 in Haryana, 37 in the UK, and 73 in other sites in India and Pakistan. NDM-1 was mostly found among Escherichia coli (36) and Klebsiella pneumoniae (111), which were highly resistant to all antibiotics except to tigecycline and colistin. K pneumoniae isolates from Haryana were clonal but NDM-1 producers from the UK and Chennai were clonally diverse. Most isolates carried the NDM-1 gene on plasmids: those from UK and Chennai were readily transferable whereas those from Haryana were not conjugative. Many of the UK NDM-1 positive patients had travelled to India or Pakistan within the past year, or had links with these countries. The potential of NDM-1 to be a worldwide public health problem is great, and co-ordinated international surveillance is needed.

1 December 2009 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
DYDongeun Yong
Dongeun Yong
Mark TolemanMark Toleman
Mark Toleman
CGChristian G. Giske
Christian G. Giske
HCHyun S. Cho
Hyun S. Cho
KSKristina Sundman
Kristina Sundman
TWTimothy R. Walsh
Timothy R. Walsh
A Swedish patient of Indian origin traveled to New Delhi, India, and acquired a urinary tract infection caused by a carbapenem-resistant Klebsiella pneumoniae strain that typed to the sequence type 14 complex. The isolate, Klebsiella pneumoniae 05-506, was shown to possess a metallo-β-lactamase (MBL) but was negative for previously known MBL genes. Gene libraries and amplification of class 1 integrons revealed three resistance-conferring regions; the first contained bla CMY-4 flanked by IS EcP1 and blc . The second region of 4.8 kb contained a complex class 1 integron with the gene cassettes arr - 2 , a new erythromycin esterase gene; ereC ; aadA1 ; and cmlA7 . An intact IS CR1 element was shown to be downstream from the qac / sul genes. The third region consisted of a new MBL gene, designated bla NDM-1 , flanked on one side by K. pneumoniae DNA and a truncated IS 26 element on its other side. The last two regions lie adjacent to one another, and all three regions are found on a 180-kb region that is easily transferable to recipient strains and that confers resistance to all antibiotics except fluoroquinolones and colistin. NDM-1 shares very little identity with other MBLs, with the most similar MBLs being VIM-1/VIM-2, with which it has only 32.4% identity. As well as possessing unique residues near the active site, NDM-1 also has an additional insert between positions 162 and 166 not present in other MBLs. NDM-1 has a molecular mass of 28 kDa, is monomeric, and can hydrolyze all β-lactams except aztreonam. Compared to VIM-2, NDM-1 displays tighter binding to most cephalosporins, in particular, cefuroxime, cefotaxime, and cephalothin (cefalotin), and also to the penicillins. NDM-1 does not bind to the carbapenems as tightly as IMP-1 or VIM-2 and turns over the carbapenems at a rate similar to that of VIM-2. In addition to K. pneumoniae 05-506, bla NDM-1 was found on a 140-kb plasmid in an Escherichia coli strain isolated from the patient's feces, inferring the possibility of in vivo conjugation. The broad resistance carried on these plasmids is a further worrying development for India, which already has high levels of antibiotic resistance.

1 April 2005 in Clinical Microbiology Reviews
Verified
Journal Article
Closed access
PDF file
TWTimothy R. Walsh
Timothy R. Walsh
Mark TolemanMark Toleman
Mark Toleman
LPLaurent Poirel
Laurent Poirel
PNPatrice Nordmann
Patrice Nordmann
SUMMARY: The ascendancy of metallo-β-lactamases within the clinical sector, while not ubiquitous, has nonetheless been dramatic; some reports indicate that nearly 30% of imipenem-resistantPseudomonas aeruginosastrains possess a metallo-β-lactamase. Acquisition of a metallo-β-lactamase gene will invariably mediate broad-spectrum β-lactam resistance inP. aeruginosa, but the level of in vitro resistance inAcinetobacterspp. and Enterobacteriaceae is less dependable. Their clinical significance is further embellished by their ability to hydrolyze all β-lactams and by the fact that there is currently no clinical inhibitor, nor is there likely to be for the foreseeable future. The genes encoding metallo-β-lactamases are often procured by class 1 (sometimes class 3) integrons, which, in turn, are embedded in transposons, resulting in a highly transmissible genetic apparatus. Moreover, other gene cassettes within the integrons often confer resistance to aminoglycosides, precluding their use as an alternative treatment. Thus far, the metallo-β-lactamases encoded on transferable genes include IMP, VIM, SPM, and GIM and have been reported from 28 countries. Their rapid dissemination is worrisome and necessitates the implementation of not just surveillance studies but also metallo-β-lactamase inhibitor studies securing the longevity of important anti-infectives.

1 May 2011 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
TWTimothy R. Walsh
Timothy R. Walsh
JWJanis Weeks
Janis Weeks
DLDavid M Livermore
David M Livermore
Mark TolemanMark Toleman
Mark Toleman

1 June 2006 in Microbiology and Molecular Biology Reviews
Verified
Journal Article
Closed access
Mark TolemanMark Toleman
Mark Toleman
PBPeter M. Bennett
Peter M. Bennett
TWTimothy R. Walsh
Timothy R. Walsh
SUMMARY: “Common regions” (CRs), such as Orf513, are being increasingly linked to mega-antibiotic-resistant regions. While their overall nucleotide sequences show little identity to other mobile elements, amino acid alignments indicate that they possess the key motifs of IS 91 -like elements, which have been linked to the mobility ent plasmids in pathogenic Escherichia coli . Further inspection reveals that they possess an IS 91 -like origin of replication and termination sites ( ter IS), and therefore CRs probably transpose via a rolling-circle replication mechanism. Accordingly, in this review we have renamed CRs as IS CR s to give a more accurate reflection of their functional properties. The genetic context surrounding IS CR s indicates that they can procure 5′ sequences via misreading of the cognate ter IS, i.e., “unchecked transposition.” Clinically, the most worrying aspect of IS CR s is that they are increasingly being linked with more potent examples of resistance, i.e., metallo-β-lactamases in Pseudomonas aeruginosa and co-trimoxazole resistance in Stenotrophomonas maltophilia . Furthermore, if IS CR elements do move via “unchecked RC transposition,” as has been speculated for IS CR 1, then this mechanism provides antibiotic resistance genes with a highly mobile genetic vehicle that could greatly exceed the effects of previously reported mobile genetic mechanisms. It has been hypothesized that bacteria will surprise us by extending their “genetic construction kit” to procure and evince additional DNA and, therefore, antibiotic resistance genes. It appears that IS CR elements have now firmly established themselves within that regimen.

20 July 2016 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
PCPeter Collignon
Peter Collignon
JCJohn M. Conly
John M. Conly
AAAntoine Andremont
Antoine Andremont
SMScott A. McEwen
Scott A. McEwen
AAAwa Aidara-Kane
Awa Aidara-Kane
GWGun-Jo Woo
Gun-Jo Woo
Antimicrobial use in food animals selects for antimicrobial resistance in bacteria, which can spread to people. Reducing use of antimicrobials—particularly those deemed to be critically important for human medicine—in food production animals continues to be an important step for preserving the benefits of these antimicrobials for people. The World Health Organization ranking of antimicrobials according to their relative importance in human medicine was recently updated. Antimicrobials considered the highest priority among the critically important antimicrobials were quinolones, third- and fourth-generation cephalosporins, macrolides and ketolides, and glycopeptides. The updated ranking allows stakeholders in the agriculture sector and regulatory agencies to focus risk management efforts on drugs used in food animals that are the most important to human medicine. In particular, the current large-scale use of fluoroquinolones, macrolides, and third-generation cephalosporins and any potential use of glycopeptides and carbapenems need to be addressed urgently.